[1]《中國(guó)中樞神經(jīng)系統(tǒng)膠質(zhì)瘤診斷和治療指南》編寫(xiě)組．中國(guó)中樞神經(jīng)系統(tǒng)膠質(zhì)瘤診斷和治療指南（2012）．中華醫(yī)學(xué)雜志，2013，93：2418-2449．

[2]NCCN Clinical practice guidelines in oncology（NCCN Guidelines）：Central nervous system cancers．Version 2013．

[3]Herholz K，Langen KJ，Schiepers C，et al．Brain tumors．Semin Nucl Med，2012，42：356-370．

[4]Chen W．Clinical applications of PET in brain tumors．J Nucl Med，2007，48：1468-1481．

[5]Heiss WD，Raab P，Lenfermann H．Multimodality assessment of brain tumors and tumor recurrence．J Nucl Med，2011，52：1585-1600．

[6]Boss A，Bisdas S，Kolb A，et al．Hybrid PET/MRI of intracranial masses：initial experiences and comparison to PET/CT．J Nucl Med，2010，51：1198-1205．

[7]Chung JK，Kim YK，Kim SK，et al．Usefulness of ^11C-methlonine PET in the evaluation of brain lesions that are hypo- or isometabolic on ¹⁸F-FDG PET．Eur J Nucl Med Mol Imaging，2002，29：176-182．

[8]Rapp M，Heinzel A，Galldiks N，et al．Diagnostic performance of ¹⁸F-FET PET in newly diagnosed cerebral lesions suggestive of glioma．J Nucl Med，2013，54：229-235．

[9]Dunet V，Rossier C，Buck A，et al．Performance of ¹⁸F-Fluoro-ethyl-tyrosine（ ¹⁸F-FET）PET for the differential diagnosis of primary brain tumor：a systematic review and meta analysis．J Nucl Med，2012，53：207-214．

[10]Tralins KS，Douglas JG，Stelzer KJ，et al．Volumetric analysis of ¹⁸F-FDG PET in glioblastoma multiforme：prognostic information and possible role in definition of target volumes in radiation dose escalation．J Nucl Med，2002，43：1667-1673．

[11]Attanasi F，Belcari N，Camarda M，et al．Experimental validation of the filtering approach for dose monitoring in proton therapy at low energy．Phys Med，2008，24：102-106．

[12]Grosu AL，Weber WA，F(xiàn)ranz M，et al．Reirradiation of recurrent high-grade gliomas using amino acid PET（SPECT）/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy． Int J Radiat Oncol Biol Phys，2005，63：511-519．

[13]Nuutinen J，Sonninen P，Lehikoinen P，et al．Radiotherapy treatment planning and long term follow-up with [（11）C]methionine PET in patients with low-grade astrocytoma．Int J Radiat Oncol Biol Phys，2000，48：43-52．

[14]Patronas NJ，Di Chiro G，Kufta C，et al．Prediction of survival in glioma patients by means of positron emission tomography．J Neurosurg，1985，62：816-822．

[15]Padma MV，Said S，Jacobs M，et al．Prediction of pathology and survival by FDG PET in gliomas．J Neurooncol，2003，64：227-237．